EUROMEDICA  Hanover 1-2  Juni 2007	Advanced methods of diagnosis, treatment and prophylactics
	European Academy of Natural Sciences, Hanover European Scientific Society, Hanover Russian Academy of Natural Sciences, Moscow

Home

Abstracts

Contact

Disclaimer

Bronchial asthma as a cause of death takes one of the leading ranks in many countries of the world. It is a known fact that mortality rate due to bronchial asthma increases during the epidemic of acute respiratory viral infections. The main cause of death at bronchial asthma is respiratory distress with sever status asthmaticus, as well as drugs overdose, such as, р - blockers.

Growth of bronchopulmonary diseases, especially bronchial asthma is visibly noticeable in recent years. But the most frustrating fact is growth of this pathology in children and infants. There several reasons for this: environmental problems, immune status damage, increase of acute respiratory viral infections that usually trigger the development of bronchial asthma, especially among children. A frequent risk factor for this disease in children is immunization that is widespread nowadays. This is responsible for spread of bronchial asthma in very young children in last decades.

The main aspect in pathogenesis of bronchial asthma in not only acute bronchial blocking, but “hypersensitivity’ of bronchial tubes with the background of an inflammatory process.

Allopathic pharmacology proposes a great number of drugs used for treatment of bronchial asthma: bronchodilator and expectorant, receptor blockers, antibiotics, antihistaminic and hormonal drugs. Unfortunately all these drugs give temporary and often fugitive remission with sever side effects: dysbacteriosis, allergic reactions, dysfunction of GIT, liver, kidney, myocardium dystrophy, tachycardia, hypertension, etc.

On the assumption of all mentioned above, one of the possible therapies especially in pediatrics is phyto- and phytochitodes therapy, having millenary experience. Vast database of observations and results of treatment of bronchial asthma was collected during the past 30 years.

The objective in view of the present article is the results phyto- and phytochitodes therapy of bronchial asthma in children from 0 to 15 years old.

Total number of 225 children of this age group was treated during the past 30 years.

123 children of this group totally recovered after application of the phyto- and phytochitodes therapy, a significant improvement was observed in 86 children. 14 patients didn’t respond to the treatment; worsening was observed only in two cases.

Based on age groups the highest recovery rate is observed in children of elder age group: from 5 to 12 - 58,2%, from 3 to 5 - 51,3%; medium recovery rate in infants - from 0 to 1 - 45,5%, the least - in age group from 1 to 3 - 35,3%. Improvement and significant improvement was observed: in age groups accordingly: from 0 to 1- 54,5%, from 1 to 3 - 64,7%, from 3 to 5 - 46,2%, from 5 to 15 - 32,3%.

Long-term experience of bronchial asthma treatment with phyto-therapeutic methods using phytochitodeses enables us to make a conclusion (supported by collected statistical data) that recovery rate and rate of significant improvement with herbal therapy in children (up to 14-15 years old) is significantly higher than in adults and in girls is higher than in boys. The treatment is more effective in early age. Allopathic methods of treatment of bronchial asthma give serious complications and side effects on many organs and systems in child’s body. That is very dangerous because a child’s body is very delicate.

Taking into consideration high coast-benefit of phyto- and phytochitodes therapy of bronchial asthma in children, as well as absence of side effects and complications during treatment, phyto-therapy of bronchial asthma with phytochitodeses and herbal teas in children is the only alternative to the conventional treatment.